6 related news articles for Blood cancer
-
RNA offers hope for new Parkinson’s treatment
An RNA-based gene therapy treatment for Parkinson’s disease that could slow and possibly even stop the condition is now a big step closer.… Read more
-
Lymphoma treatment targets multiple diseases
The search for new therapies to treat a rare type of non-Hodgkins lymphoma has had an unexpected success – identifying a potential molecular target to treat other related forms of lymphoma as well.… Read more
-
Pioneering work attracts VCA cancer fellowships
Two Hudson Institute researchers at different stages of their careers have won sought-after Victorian Cancer Agency (VCA) Fellowships. Blood cancer specialist Dr Catherine Carmichael received the VCA Mid-Career Research Fellowship for her research into Acute Myeloid Leukaemia (AML), while Dr Claire Sun was awarded the VCA Early Career Research Fellowship to further her search for… Read more
-
Blood cancer – frequently asked questions
Dr Catherine Carmichael answers frequently asked questions about blood cancer. Dr Carmichael is a molecular cancer biologist and Head of the Leukaemia Modelling and Therapeutic Discovery Research group within the Centre for Cancer Research at Hudson Institute.… Read more
-
Targeting childhood cancer | Jaxon’s story
Sarah Russell knew something was gravely wrong with one of her twins, five-year-old Jaxon, when he became seriously ill with vomiting, nausea and unusual bruising, while his brother, Hunter, remained well.… Read more
-
VCA funding for Hudson Institute researchers
MIMR-PHI cancer researchers, Drs George Grigoriadis and Daniel Gough were among 25 scientists recently awarded VCA funding.… Read more
